§ CERTIFICATE OF ANALYSIS · THIRD-PARTY HPLC · FEB-2026● VERIFIED SUBMISSION · PUBLIC RECORD

Home › Lab Tests › NEXAPH, Retatrutide

◆ Batch ID · NXP-3P2401262026-13✓ Verified · Pass

Retatrutide × NEXAPH - Lab Test, February 2026

Tested Monday, February 09, 2026 · submitted by @Frank 👑 Legend

HPLC Purity

99.22%

✓ Excellent

PeptideRetatrutide

Brandnexaph

LabJanoshik Labs

↓ Download COA 🔗 Share

Test results

7 data points

Purity

99.22%

Endotoxins

Not tested

Stated qty

24 mg

Tested qty

28.55 mg

Qty match

119% of labeled · +19%

Batch ID

NXP-3P2401262026-13

Container

Transparent Purple/Black

Tested by

Janoshik LabsView profile →

◆ Quantity verification

24 mg→28.55 mg+19%

About this test

This independent HPLC lab test confirms Retatrutide 28.55mg from NEXAPH at 99.225% purity. The analysis was conducted by Janoshik Labs on February 9, 2026.

Retatrutide is a triple GLP-1/GIP/GCN receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. A purity level of 99.225% indicates minimal contamination and high-grade synthesis.

The full certificate of analysis is available for verification at www.janoshik.com with the unique key UI9Q41JGRZ66.